Laniquidar TFA
Laniquidar (R101933) is a novel, orally available non-competitive P-glycoprotein inhibitor (IC50 = 0.51 μM) used to study multidrug resistance modulation. Its research applications include investigating acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Purity
98.74% (May vary between batches)
Smiles
O=C (C1=CN=C2/C (C3=C (CCN21) C=CC=C3) =C4CCN (CC\4) CCC5=CC=C (C=C5) OCC6=NC7=C (C=C6) C=CC=C7) OC.OC (C (F) (F) F) =O
Molecular Formula
C39H37F3N4O5
Molecular Weight
698.73
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9006940 Inquire
Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) At5g22700 Polyclonal Antibody
Sign In for Pricing
View Details K0630407 1.0 µg DNA
DPY19L2P2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details AFG-ELL-3628-01 125 mL
Culture Medium for Human Small Cell Lung Cancer Cells [DMS 114]
Sign In for Pricing
View Details AFG-ELL-3628-02 500 mL
Culture Medium for Human Small Cell Lung Cancer Cells [DMS 114]
Sign In for Pricing
View Details